Milestone Pharmaceuticals Investor Relations Material
Latest events
Investor Update
Milestone Pharmaceuticals
Q1 2025
14 May, 2025
Q4 2024
13 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Milestone Pharmaceuticals Inc
Access all reports
Milestone Pharmaceuticals Inc. is a biopharmaceutical company focused on developing cardiovascular therapies. The company specializes in the research and development of treatments for episodic cardiovascular conditions, aiming to provide rapid and effective symptom relief. Its lead drug candidates target conditions such as paroxysmal supraventricular tachycardia (PSVT) and other heart-related disorders. The company is headquartered in Montreal, Canada, and its shares are listed on the NASDAQ.
Key slides for Milestone Pharmaceuticals Inc
TD Cowen 45th Annual Healthcare Conference
Milestone Pharmaceuticals Inc
TD Cowen 45th Annual Healthcare Conference
Milestone Pharmaceuticals Inc
Latest articles
)
Ron Vachris: From Forklift Driver to CEO at Costco
Ron Vachris took over as Costco CEO in 2024, following a 40-year journey from warehouse floors to the top of one of retail's most admired companies.
18 Jun 2025
)
Luca de Meo: Succeeding Pinault as the New CEO of Kering
Luca de Meo's leap from auto to luxury marks a bold new chapter as he becomes the first non-Pinault CEO to lead the Kering empire.
16 Jun 2025
)
Airbnb: The Hospitality Giant Without Property
Airbnb has grown from an idea to help the Co-Founders make rent, to one of the most dominant companies in the global hospitality industry.
13 Jun 2025
Ticker symbol
MIST
Country
🇨🇦 Canada